Intuitive Surgical(IT:1ISRG)
€404.15+4.75 (+1.19%)
IT:1ISRG
Intuitive Surgical stock drug pipeline
€404.15
At close:+4.75 (+1.19%)
Intuitive Surgical (1ISRG) Drug Pipeline
14 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Intuitive Surgical (IT:1ISRG) have in its pipeline
Intuitive Surgical IT:1ISRG is currently developing the following drugs: Shape-Sensing Robotic-Assisted Bronchoscopy With Cone-Beam Ct, Ct-Guided Percutaneous Lung Nodule Biopsy, Ion Endoluminal System, Filricianine, Administration Of Is-002, Firefly Fluorescent Imaging, Robotic-Assisted Laparoscopic Prostatectomy With Pelvic Lymph Node Dissection, Is-001, Is-002, No Treatment, Is-001, Is-001, Da Vinci Si/Xi Surgical System. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

